Page last updated: 2024-10-18

glycine and Ophthalmoplegia, Progressive Supranuclear

glycine has been researched along with Ophthalmoplegia, Progressive Supranuclear in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vilas, D1
Sharp, M1
Gelpi, E1
Genís, D1
Marder, KS1
Cortes, E1
Vonsattel, JP1
Tolosa, E1
Alcalay, RN1
Choumert, A1
Poisson, A1
Honnorat, J2
Le Ber, I1
Camuzat, A1
Broussolle, E1
Thobois, S2
Ros, R1
Streichenberger, N1
Kopp, N1
Sánchez, MP1
Pérez, M1
Hoenicka, J1
Avila, J1
de Yébenes, JG1

Other Studies

3 other studies available for glycine and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers.
    Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:2

    Topics: Aged; Astrocytes; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Locus Coer

2018
G303V tau mutation presenting with progressive supranuclear palsy-like features.
    Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:4

    Topics: Adult; DNA Mutational Analysis; Exons; Family Health; Glycine; Humans; Middle Aged; Supranuclear Pal

2012
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.
    Archives of neurology, 2005, Volume: 62, Issue:9

    Topics: Amino Acid Substitution; Blotting, Northern; Blotting, Western; Brain; Dihydroxyphenylalanine; DNA M

2005